ChemoCentryx Inc

Research ChemoCentryx Inc (CCXI) on Bullrun: valuation model: 56.4% overvalued, market cap USD 913.48M, P/E 253.5. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCCXI
• ExchangeNASDAQ
• CountryUnited States
• SectorFinancial Services
• IndustryShell Companies
• CurrencyUSD
• Valuation signal56.4% overvalued
• Market capUSD 913.48M
• P/E253.5
• Financial periodQ1 2026
• Net incomeUSD 3.17M
• Free cash flow-USD 326.11K

Valuation Snapshot

Bullrun's latest valuation model marks ChemoCentryx Inc as 56.4% overvalued; latest market cap is USD 913.48M; P/E is 253.5.

About ChemoCentryx Inc

Churchill Capital Corp XI does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in New York, New York.

Frequently asked questions

Is ChemoCentryx Inc overvalued or undervalued?

Bullrun's valuation model currently marks ChemoCentryx Inc as 56.4% overvalued.

What is ChemoCentryx Inc's market cap?

ChemoCentryx Inc's market capitalization is USD 913.48M.

What is ChemoCentryx Inc's P/E ratio?

ChemoCentryx Inc's price-to-earnings (P/E) ratio is 253.5.

What does ChemoCentryx Inc do?

Churchill Capital Corp XI does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.